• SGLT-2 inhibitors may prevent AKI in older adults with type 2 diabetes

    1 month ago - By Healio

    The initiation of SGLT-2 inhibitors correlated with a reduced risk of AKI in older adults with type 2 diabetes compared with other glucose-lowering medications.
    According to data published in the American Journal of Kidney Diseases, SGLT-2 inhibitors may prevent AKI events.
    “SGLT-2i have been found to have many benefits for patients with type 2 diabetes. However, whether SGLT-2i increase the risk of AKI remains unknown,” Elisabetta Patorno, MD, DrPH, associate professor of medicine in the division of pharmacoepidemiology and pharmacoeconomics in the department of
    Read more ...

     

  • Ticagrelor-aspirin DAPT reduces risk for different types of MI

    Ticagrelor-aspirin DAPT reduces risk for different types of MI

    1 month ago - By Healio

    Ticagrelor added to low-dose aspirin reduced the risk for spontaneous MI, MI related to stent thrombosis and STEMI compared with placebo in patients with diabetes and CAD, according to a new analysis of the THEMIS trial.
    Jérémie Abtan, MD, PhD, interventional cardiologist at Assistance Publique - Hôpitaux de Paris, France, and colleagues reported results of an analysis of the incidence of MI types in patients treated with ticagrelor in the THEMIS trial. Their findings were published in a research letter in Circulation: Cardiovascular Interventions.
    In the main
    Read more ...